Breast Cancer Risk Assessment and Surveillance

Quantitative Risk Comparison

The American College of Radiology and National Comprehensive Cancer Network recommend that women with a personal history of breast cancer are at substantially higher risk than those with family history alone, particularly when diagnosed before age 50 1, 2
A personal history of breast cancer confers an absolute risk of 0.5-1% per year, translating to 5-10% cumulative risk over 10 years following initial diagnosis 3
Women with a personal history of breast cancer are at a higher risk than those with family history alone, with a 2-6 fold increased risk compared to the general population is not included as it has an ignore ref, however, risk varies widely depending on number and age of affected relatives 4, 5
A single first-degree relative with breast cancer typically confers a 15-20% lifetime risk (moderate risk category) 5

The American College of Radiology recommends enhanced surveillance for women with personal history, particularly when combined with additional risk factors, including annual mammography starting 6-12 months after completing treatment 6, 2
Annual breast MRI is recommended for women with personal history and dense breasts, or diagnosis before age 50 6, 2, 1
MRI demonstrates 85% sensitivity versus 23% for mammography alone in this population 1
Cancer detection rate with MRI: 10-29 per 1,000 women with personal history 1
For women with family history alone, screening intensity depends on calculated lifetime risk, with moderate risk (15-20% lifetime) requiring annual mammography starting age 30 or 5-10 years before youngest family case, and consider MRI 5
High risk (>20% lifetime or genetic mutation) requires annual mammography and MRI starting age 25-30 5, 1

The Gail model systematically underestimates risk in women with personal history of atypical hyperplasia or LCIS, making it inappropriate for risk assessment in these populations 4
The Tyrer-Cuzick model is more appropriate when personal history factors are present 4
The evidence clearly demonstrates that personal history of breast cancer represents a higher absolute annual risk (0.5-1% per year) compared to family history alone, which typically confers cumulative lifetime risk that must be calculated using risk models 3, 4

Women with two first-degree relatives with breast cancer, or specific high-risk patterns, may reach the >20% lifetime threshold requiring high-risk management, as recommended by the National Comprehensive Cancer Network 7, 8
Age is the most important risk factor in the general population, with risk increasing progressively with advancing age, according to the American Cancer Society 9

The Tyrer-Cuzick model is more appropriate for risk assessment in women with personal history of atypical hyperplasia or LCIS, as it can analyze first- and second-degree relatives on both maternal and paternal sides 8, 10, 11
Specialized models such as BRCAPRO, BOADICEA, Claus, or Tyrer-Cuzick models should be used for family history assessment, as recommended by the National Comprehensive Cancer Network 8, 12, 10, 11

Women with only one first-degree relative typically do not meet criteria for MRI screening, according to the American Cancer Society 12
The American College of Radiology and National Comprehensive Cancer Network recommend annual mammography and MRI for women with personal history of breast cancer, particularly when combined with dense breasts or diagnosis before age 50 7, 8